+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Left Atrial Appendage Closure Market 2020-2024 - Product Image

Global Left Atrial Appendage Closure Market 2020-2024

  • ID: 5157110
  • Report
  • September 2020
  • Region: Global
  • 120 pages
  • TechNavio

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Aegis Medical Group
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • MORE
Global Left Atrial Appendage Closure Market 2020-2024

The left atrial appendage closure market is poised to grow by USD 1.64 bn during 2020-2024, progressing at a CAGR of 30% during the forecast period. The reports on left atrial appendage closure market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidences of atrial fibrillation and potential long-term cost-effectiveness associated with the use of LAA closure devices. In addition, increasing incidences of atrial fibrillation is anticipated to boost the growth of the market as well.
The left atrial appendage closure market analysis includes the product segment and geographical landscapes.

The left atrial appendage closure market is segmented as below:

By Product
  • Epicardial LAA closure device
  • Endocardial LAA closure device
By Geographical Landscapes
  • Europe
  • North America
  • APAC
  • ROW
This study identifies the growing product approvals fueling market growth as one of the prime reasons driving the left atrial appendage closure market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

The left atrial appendage closure market covers the following areas:
  • Left atrial appendage closure market sizing
  • Left atrial appendage closure market forecast
  • Left atrial appendage closure market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading left atrial appendage closure market vendors that include Abbott Laboratories, Aegis Medical Group, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Carestream Health Inc., Johnson & Johnson, Lifetech Scientific (Shenzhen) Co. Ltd., and Occlutech International AB. Also, the left atrial appendage closure market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Aegis Medical Group
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Product
  • Market segments
  • Comparison by Product
  • Epicardial LAA closure device - Market size and forecast 2019-2024
  • Endocardial LAA closure device - Market size and forecast 2019-2024
  • Market opportunity by Product
Market Segmentation by End-user

Customer Landscape

Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume drivers – Demand led growth
  • Volume drivers – External factors
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Aegis Medical Group
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • Carestream Health Inc.
  • Johnson & Johnson
  • Lifetech Scientific (Shenzhen) Co. Ltd.
  • Occlutech International AB
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Product - Market share 2019-2024 (%)
22: Comparison by Product
23: Epicardial LAA closure device - Market size and forecast 2019-2024 ($ million)
24: Epicardial LAA closure device - Year-over-year growth 2019-2024 (%)
25: Endocardial LAA closure device - Market size and forecast 2019-2024 ($ million)
26: Endocardial LAA closure device - Year-over-year growth 2019-2024 (%)
27: Market opportunity by Product
28: Customer Landscape
29: Market share by geography 2019-2024 (%)
30: Geographic comparison
31: Europe - Market size and forecast 2019-2024 ($ million)
32: Europe - Year-over-year growth 2019-2024 (%)
33: North America - Market size and forecast 2019-2024 ($ million)
34: North America - Year-over-year growth 2019-2024 (%)
35: APAC - Market size and forecast 2019-2024 ($ million)
36: APAC - Year-over-year growth 2019-2024 (%)
37: ROW - Market size and forecast 2019-2024 ($ million)
38: ROW - Year-over-year growth 2019-2024 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Abbott Laboratories - Overview
48: Abbott Laboratories - Business segments
49: Abbott Laboratories - Key offerings
50: Abbott Laboratories - Key customers
51: Abbott Laboratories - Segment focus
52: Aegis Medical Group - Overview
53: Aegis Medical Group - Product and service
54: Aegis Medical Group - Key offerings
55: Aegis Medical Group - Key customers
56: Aegis Medical Group - Segment focus
57: Append Medical - Overview
58: Append Medical - Product and service
59: Append Medical - Key offerings
60: Append Medical - Key customers
61: Append Medical - Segment focus
62: AtriCure Inc. - Overview
63: AtriCure Inc. - Business segments
64: AtriCure Inc. - Key offerings
65: AtriCure Inc. - Key customers
66: AtriCure Inc. - Segment focus
67: Boston Scientific Corp. - Overview
68: Boston Scientific Corp. - Business segments
69: Boston Scientific Corp. - Key offerings
70: Boston Scientific Corp. - Key customers
71: Boston Scientific Corp. - Segment focus
72: Cardia Inc. - Overview
73: Cardia Inc. - Product and service
74: Cardia Inc. - Key offerings
75: Cardia Inc. - Key customers
76: Cardia Inc. - Segment focus
77: Carestream Health Inc. - Overview
78: Carestream Health Inc. - Product and service
79: Carestream Health Inc. - Key offerings
80: Carestream Health Inc. - Key customers
81: Carestream Health Inc. - Segment focus
82: Johnson & Johnson - Overview
83: Johnson & Johnson - Business segments
84: Johnson & Johnson - Key offerings
85: Johnson & Johnson - Key customers
86: Johnson & Johnson - Segment focus
87: Lifetech Scientific (Shenzhen) Co. Ltd. - Overview
88: Lifetech Scientific (Shenzhen) Co. Ltd. - Business segments
89: Lifetech Scientific (Shenzhen) Co. Ltd. - Key offerings
90: Lifetech Scientific (Shenzhen) Co. Ltd. - Key customers
91: Lifetech Scientific (Shenzhen) Co. Ltd. - Segment focus
92: Occlutech International AB - Overview
93: Occlutech International AB - Product and service
94: Occlutech International AB - Key offerings
95: Occlutech International AB - Key customers
96: Occlutech International AB - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Aegis Medical Group
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • MORE
The publisher recognizes the following companies as the key players in the global left atrial appendage closure market: Abbott Laboratories, Aegis Medical Group, Append Medical, AtriCure Inc., Boston Scientific Corp., Cardia Inc., Carestream Health Inc., Johnson & Johnson, Lifetech Scientific (Shenzhen) Co. Ltd., and Occlutech International AB.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing product approvals."

According to the report, one of the major drivers for this market is the increasing incidences of atrial fibrillation.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Abbott Laboratories
  • Aegis Medical Group
  • Append Medical
  • AtriCure Inc.
  • Boston Scientific Corp.
  • Cardia Inc.
  • Carestream Health Inc.
  • Johnson & Johnson
  • Lifetech Scientific (Shenzhen) Co. Ltd.
  • Occlutech International AB
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll